Tweet
Thromb Res
. 2021 Feb 17;201:23-29.
doi: 10.1016/j.thromres.2021.02.010. Online ahead of print.
Incidence and impact of disseminated intravascular coagulation in COVID-19 a systematic review and meta-analysis
Xianghui Zhou 1 , Zhipeng Cheng 1 , Lili Luo 1 , Ying Zhu 2 , Wenyi Lin 1 , Zhangyin Ming 3 , Wei Chen 4 , Yu Hu 5
Affiliations
- PMID: 33631519
- DOI: 10.1016/j.thromres.2021.02.010
Abstract
Objectives: Coronavirus disease 2019 (COVID-19) is a novel infectious disease, with significant morbidity and mortality. This meta-analysis is to evaluate the prevalence of disseminated intravascular coagulation (DIC) in COVID-19 patients and to determine the association of DIC with the severity and prognosis of COVID-19.
Methods: We searched the PubMed, EMBASE, and China National Knowledge Infrastructure (CNKI) database until August 12, 2020. The meta-analysis was performed using Stata 16.0 software.
Results: 14 studies were included in our meta-analysis. The pooled analysis revealed that the incidence of COVID-19 patients developing DIC was 3% (95%: 1%-5%, P < 0.001). In addition, deaths were more likely to be associated with DIC (Log OR = 2.46, 95% CI: 0.94-3.99, P < 0.001) with statistical significance.
Conclusions: DIC is associated with the severity and poor prognosis of COVID-19 patients. Therefore, attention should be paid to coagulation dysfunction in COVID-19 patients. Monitoring of coagulation indicators may improve the prognosis of COVID-19 inpatients.
Keywords: Coronavirus disease 2019 (COVID-19); Disseminated intravascular coagulation; SARS-CoV-2.